ACM
IONS icon

Aquatic Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History

Aquatic Capital Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.38M Sell
42,581
-104,798
-71% -$7.89M 0.12% 224
2026
Q1 		$11.1M Buy
147,379
+14,553
+11% +$1.15M 0.32% 76
2025
Q4 		$10.5M Sell
132,826
-26,219
-16% -$1.97M 0.3% 76
2025
Q3 		$10.4M Buy
159,045
+959
+0.6% +$46.8K 0.19% 129
2025
Q2 		$6.25M Buy
158,086
+1,929
+1% +$63.1K 0.13% 206
2025
Q1 		$4.71M Sell
156,157
-73,859
-32% -$2.42M 0.12% 225
2024
Q4 		$8.04M Buy
+230,016
New +$8.6M 0.22% 121
2024
Q2 		– Sell
-11,700
Closed -$507K – 1407
2024
Q1 		$507K Buy
11,700
+5,300
+83% +$253K 0.02% 541
2023
Q4 		$324K Buy
+6,400
New +$307K 0.01% 738
2023
Q1 		– Sell
-3,200
Closed -$121K – 1499
2022
Q4 		$121K Sell
3,200
-22,300
-87% -$938K 0.01% 836
2022
Q3 		$1.13M Buy
+25,500
New +$1.07M 0.11% 240

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Aquatic Capital Management's IONS Position: Q2 2026 in Review

Aquatic Capital Management reduced its Ionis Pharmaceuticals (IONS) stake by 71% in Q2 2026, selling an estimated $7.89M and leaving 42,581 shares worth $3.38M. The position accounts for 0.12% of the portfolio, ranked #224.

Aquatic Capital Management first reported a position in IONS in Q3 2022 and has held it in 11 quarters since. The position peaked at $11.1M in Q1 2026. 515 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Aquatic Capital Management held 42,581 shares of Ionis Pharmaceuticals worth $3.38M as of Q2 2026.
  • Aquatic Capital Management sold 104,798 Ionis Pharmaceuticals shares in Q2 2026, an estimated $7.89M.
  • Ionis Pharmaceuticals made up 0.12% of Aquatic Capital Management's portfolio in Q2 2026, its #224 holding.
  • Aquatic Capital Management first reported a position in Ionis Pharmaceuticals in Q3 2022 and has held it in 11 quarters since.
  • Aquatic Capital Management's Ionis Pharmaceuticals position peaked at $11.1M in Q1 2026.
  • 515 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.